Biotech

All Articles

F 2G increases $100M for 2nd try to receive brand new antifungal to market

.After F2G's initial effort to get a new class of antifungal to market was derailed due to the FDA, ...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 courses in the middle of profitability pressures

.Moderna has pledged to reduce R&ampD investing through $1.1 billion through 2027. The decision to r...

Sanofi's $80M bet on Pivot dystrophy medication ends in stage 3 go bust

.Simply 4 months after Sanofi wager $80 thousand in ahead of time cash money on Key Therapeutics' lo...

Oncternal share drains 60% amidst layoffs, trial discontinuations

.Cancer cells company Oncternal Therapeutics is folding all its medical trials as well as laying off...

Roche is holding out chances that its own injectable weight problems prospect might at some point display 25% weight reduction in late-stage trial

.Roche is keeping out chances that its injectable excessive weight possibility could eventually disp...

Novo Nordisk hails 'outstanding' weight-loss lead for dual-acting dental medication in very early test

.Novo Nordisk has actually elevated the lid on a period 1 test of its own dental amylin as well as G...

AbbVie takes legal action against BeiGene over blood cancer cells medication trade secrets

.Simply a handful of brief full weeks after succeeding an FDA Fast Track tag for its own investigati...

Lilly delivers one-two blow along with 2nd tranche of beneficial data on every week blood insulin prospect

.Soon after a beneficial data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based provider ...

BridgeBio reduces gene therapy spending plan as scientific information disappoint

.BridgeBio Pharma is lowering its own genetics therapy finances as well as drawing back coming from ...

GSK gives up HSV injection wishes after period 2 stop working, signing over ethnicity to Moderna, BioNTech

.GSK's try to create the 1st injection for genital herpes simplex infection (HSV) has ended in faili...